Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF DILUTIVE COMMON STOCK EQUIVALENTS (Details)

v3.22.2.2
SCHEDULE OF DILUTIVE COMMON STOCK EQUIVALENTS (Details) - shares
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 3,459,793 4,005,009
Stock Options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 929,701 550,009
Stock Warrants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 2,530,092 3,455,000